These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 17200411

  • 1. IL-25 regulates Th17 function in autoimmune inflammation.
    Kleinschek MA, Owyang AM, Joyce-Shaikh B, Langrish CL, Chen Y, Gorman DM, Blumenschein WM, McClanahan T, Brombacher F, Hurst SD, Kastelein RA, Cua DJ.
    J Exp Med; 2007 Jan 22; 204(1):161-70. PubMed ID: 17200411
    [Abstract] [Full Text] [Related]

  • 2. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo.
    Sonderegger I, Kisielow J, Meier R, King C, Kopf M.
    Eur J Immunol; 2008 Jul 22; 38(7):1833-8. PubMed ID: 18546146
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells.
    Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S, Lee J, de Sauvage FJ, Ghilardi N.
    Nat Immunol; 2006 Sep 22; 7(9):929-36. PubMed ID: 16906167
    [Abstract] [Full Text] [Related]

  • 7. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE.
    Isaksson M, Ardesjö B, Rönnblom L, Kämpe O, Lassmann H, Eloranta ML, Lobell A.
    Eur J Immunol; 2009 Oct 22; 39(10):2925-35. PubMed ID: 19637225
    [Abstract] [Full Text] [Related]

  • 8. IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivo.
    Gyülvészi G, Haak S, Becher B.
    Eur J Immunol; 2009 Jul 22; 39(7):1864-9. PubMed ID: 19544494
    [Abstract] [Full Text] [Related]

  • 9. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC, Lalor SJ, Lynch MA, Mills KH.
    Brain Behav Immun; 2010 May 22; 24(4):641-51. PubMed ID: 20138983
    [Abstract] [Full Text] [Related]

  • 10. Differential regulation of CD4(+) T helper cell responses by curcumin in experimental autoimmune encephalomyelitis.
    Kanakasabai S, Casalini E, Walline CC, Mo C, Chearwae W, Bright JJ.
    J Nutr Biochem; 2012 Nov 22; 23(11):1498-507. PubMed ID: 22402368
    [Abstract] [Full Text] [Related]

  • 11. Oral tolerance reduces Th17 cells as well as the overall inflammation in the central nervous system of EAE mice.
    Peron JP, Yang K, Chen ML, Brandao WN, Basso AS, Commodaro AG, Weiner HL, Rizzo LV.
    J Neuroimmunol; 2010 Oct 08; 227(1-2):10-7. PubMed ID: 20580440
    [Abstract] [Full Text] [Related]

  • 12. Pathophysiology of interleukin-23 in experimental autoimmune encephalomyelitis.
    Touil T, Fitzgerald D, Zhang GX, Rostami AM, Gran B.
    Drug News Perspect; 2006 Mar 08; 19(2):77-83. PubMed ID: 16628262
    [Abstract] [Full Text] [Related]

  • 13. Decoy receptor 3 ameliorates experimental autoimmune encephalomyelitis by directly counteracting local inflammation and downregulating Th17 cells.
    Chen SJ, Wang YL, Kao JH, Wu SF, Lo WT, Wu CC, Tao PL, Wang CC, Chang DM, Sytwu HK.
    Mol Immunol; 2009 Dec 08; 47(2-3):567-74. PubMed ID: 19819554
    [Abstract] [Full Text] [Related]

  • 14. Regulation of the IL-21 gene by the NF-κB transcription factor c-Rel.
    Chen G, Hardy K, Bunting K, Daley S, Ma L, Shannon MF.
    J Immunol; 2010 Aug 15; 185(4):2350-9. PubMed ID: 20639489
    [Abstract] [Full Text] [Related]

  • 15. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production.
    Xie L, Li XK, Funeshima-Fuji N, Kimura H, Matsumoto Y, Isaka Y, Takahara S.
    Int Immunopharmacol; 2009 May 15; 9(5):575-81. PubMed ID: 19539560
    [Abstract] [Full Text] [Related]

  • 16. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
    Kebir H, Ifergan I, Alvarez JI, Bernard M, Poirier J, Arbour N, Duquette P, Prat A.
    Ann Neurol; 2009 Sep 15; 66(3):390-402. PubMed ID: 19810097
    [Abstract] [Full Text] [Related]

  • 17. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells.
    Kuwabara T, Ishikawa F, Yasuda T, Aritomi K, Nakano H, Tanaka Y, Okada Y, Lipp M, Kakiuchi T.
    J Immunol; 2009 Aug 15; 183(4):2513-21. PubMed ID: 19625643
    [Abstract] [Full Text] [Related]

  • 18. IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis.
    Kreymborg K, Etzensperger R, Dumoutier L, Haak S, Rebollo A, Buch T, Heppner FL, Renauld JC, Becher B.
    J Immunol; 2007 Dec 15; 179(12):8098-104. PubMed ID: 18056351
    [Abstract] [Full Text] [Related]

  • 19. Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response.
    Oh SJ, Chung DH.
    J Immunol; 2011 Jun 15; 186(12):6815-21. PubMed ID: 21572032
    [Abstract] [Full Text] [Related]

  • 20. Interferon-γ orchestrates the number and function of Th17 cells in experimental autoimmune encephalomyelitis.
    Berghmans N, Nuyts A, Uyttenhove C, Van Snick J, Opdenakker G, Heremans H.
    J Interferon Cytokine Res; 2011 Jul 15; 31(7):575-87. PubMed ID: 21348780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.